Katja Rosenkranz Ph.D Overview
- Firm
- V-Bio Ventures
- Primary Position
-
Partner
- Primary Industry
-
Healthcare
- Active Board Seats
-
3
- Med. Deal Size
-
- Med. Valuation
-
Katja Rosenkranz Ph.D General Information
Biography
Dr. Katja Rosenkranz serves as Board Member at Dualyx. She serves as Partner at V-Bio Ventures and Jay Therapeutics. She serves as Board Observer at ExeVir Bio. She also served as Board Member at AgomAb Therapeutics. Before joining V-Bio Ventures, she spent more than 12 years in the life science venture business. She worked as an analyst at Polytechnos Venture-Partners and as CBO/CFO at Hepa Wash. Subsequently, she was a senior investment and project manager at Ascenion, where she managed the Spinnovator initiative and progressed early academic inventions to create spin-offs. She holds a Ph.D. and MSc in Biochemistry from Witten/Herdecke University, Germany, and an Executive MBA in Medical Devices and Healthcare Management from the IBST, Tuttlingen, Germany. She spent more than 12 years in the life science venture business. She worked as an analyst at PolyTechnos Venture-Partners and as CBO/CFO at Hepa Wash. Subsequently, she was a senior investment and project manager at Ascenion, where she managed the Spinnovator initiative and progressed early academic inventions to create spin-offs. She holds a Ph.D. and MSc in Biochemistry from Witten/Herdecke University, Germany, and an Executive MBA in Medical Devices and Healthcare Management from the IBST, Tuttlingen, Germany.
Contact Information
Address
- Pieter Van Ryesshootlaan 2 box 104
- Sint-Denijs-Westrem
- 9051 Ghent
- Belgium
Katja Rosenkranz Ph.D Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
V-Bio Ventures | Investor | Partner | Ghent, Belgium | Venture Capital |
Katja Rosenkranz Ph.D Board Seats (3)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Dualyx | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Ghent, Belgium | |
ExeVir | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Ghent, Belgium | |
Jay Therapeutics | Other Healthcare Services | Privately Held (backing) | Venture Capital-Backed | Gent, Belgium |
Katja Rosenkranz Ph.D Lead Partner on Deals (4)
Katja Rosenkranz Ph.D has been the lead partner on 4 deals. Their latest deal was with Dualyx, a drug discovery company. The deal was made for on 15-May-2023.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Dualyx | 15-May-2023 | Early Stage VC (Series A) | Completed | Drug Discovery | Ghent, Belgium | |
AgomAb | 13-Jul-2022 | Completed | Drug Discovery | Antwerp, Belgium | ||
ExeVir | 16-Mar-2021 | Early Stage VC (Series A) | Completed | Drug Discovery | Ghent, Belgium | |
AgomAb | 10-Oct-2019 | Early Stage VC (Series A) | Completed | Drug Discovery | Antwerp, Belgium |
Katja Rosenkranz Ph.D Network (59)
Board Members (32)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Ohad Hammer | AgomAb | Pontifax Venture Capital | Antwerp, Belgium | |
Juliette Audet | Dualyx | Forbion | Ghent, Belgium | |
ExeVir | Self | Ghent, Belgium | ||
AgomAb | Redmile Group | Antwerp, Belgium | ||
AgomAb | Self | Antwerp, Belgium |
Portfolio Executives (23)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Wouter Verhoeven | Dualyx | Chief Executive Officer | 15-May-2023 | Ghent, Belgium |
Luc Van Rompaey Ph.D | Dualyx | Founder & Chief Scientific Officer | 15-May-2023 | Ghent, Belgium |
AgomAb | Co-Founder | 13-Jul-2022 | Antwerp, Belgium | |
AgomAb | Board Member & Chairman of the Audit Committee | 13-Jul-2022 | Antwerp, Belgium | |
AgomAb | Chief Financial Officer | 13-Jul-2022 | Antwerp, Belgium |
Fund Team Members (4)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Christina Takke Ph.D | V-Bio Ventures | V-Bio Ventures Fund I | Ghent, Belgium |
Christina Takke Ph.D | V-Bio Ventures | V-Bio Ventures Fund II | Ghent, Belgium |
V-Bio Ventures | Ghent, Belgium | ||
V-Bio Ventures | Ghent, Belgium | ||
V-Bio Ventures | Ghent, Belgium |
Katja Rosenkranz Ph.D Affiliated Funds (2)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
V-Bio Ventures Fund I | V-Bio Ventures | Venture - General | Closed | 2016 | ||||
V-Bio Ventures Fund II | V-Bio Ventures | Venture - General | Closed | 2022 |
Katja Rosenkranz Ph.D FAQs
-
Who is Katja Rosenkranz Ph.D?
Dr. Katja Rosenkranz serves as Board Member at Dualyx.
-
How much does Katja Rosenkranz Ph.D typically invest?
Katja Rosenkranz Ph.D's median deal size is
. -
What is Katja Rosenkranz Ph.D’s main position?
Katja Rosenkranz Ph.D’s primary position is Partner.
-
How many active board seats does Katja Rosenkranz Ph.D hold?
Katja Rosenkranz Ph.D holds 3 board seats including Dualyx, ExeVir, and Jay Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »